Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03748017 · ClinicalTrials.gov registry record · NA
The Probiotic for Oral Health (PRO Health) Study
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT03748017: Completed NA study, sponsored by University of California, Davis.
NCT03748017 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03748017, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The PRO Health Study is a single-center, prospective, double-blind, randomized, placebo-controlled trial of streptococcus-containing supplementation in healthy adults.
Primary Outcome
The difference in levels of oral Streptococci between a streptococcus-containing probiotic supplement (e.g., S. salivarius K12) and placebo-control supplement on Day 22.
Interventions
- DIETARY_SUPPLEMENT Placebo-Control Supplement
- DIETARY_SUPPLEMENT Streptococcus-Containing Probiotic Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-09-04 |
| Est. Completion | 2021-10-01 |
| Phase | NA |
What the finished NCT03748017 record still lists
NCT03748017 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo-Control Supplement is the first listed.
NCT03748017 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03748017 about?
NCT03748017 is a clinical study titled "The Probiotic for Oral Health (PRO Health) Study". The PRO Health Study is a single-center, prospective, double-blind, randomized, placebo-controlled trial of streptococcus-containing supplementation in healthy adults.
What is the current status of trial NCT03748017?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2018-09-04. Estimated completion is 2021-10-01.
What interventions are being tested in trial NCT03748017?
The interventions under investigation include: Placebo-Control Supplement (DIETARY_SUPPLEMENT), Streptococcus-Containing Probiotic Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03748017?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03748017's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI